AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Feb 14, 2022

What to do about alopecia areata?

Combining treatments may be best.


Brittany Craiglow, MD, FAAD.
Brittany Craiglow, MD, FAAD.

U012 – Alopecia Areata Power Hour

Friday, March 25 | 4:30 pm - 5:30 pm

Room: 253A

While it remains a complex disease, more effective and reliable treatments for alopecia areata may be on the horizon. The emergence of Janus kinase (JAK) inhibitors represents promise and a pathogenesis-directed therapeutic, according to Brittany Craiglow, MD, FAAD, associate professor of dermatology at Yale University School of Medicine. Dr. Craiglow will offer a new perspective on this devastating disease during the session, U012 – Alopecia Areata Power Hour.

“Alopecia areata (AA) is quite common, with a lifetime risk of around 2%. The etiology of AA is multifactorial, involving genetic predisposition, loss of hair follicle’s immune privilege, and immune dysregulation,” Dr. Craiglow said. “Yet, AA is far more than ‘just hair loss.’ It frequently has a profound impact on quality of life of both affected patients and family members.”  

According to Dr. Craiglow, while there are currently no FDA-approved therapies for alopecia areata, traditional treatment options have included intralesional, topical, and systemic corticosteroids, topical irritants, minoxidil, and systemic immunomodulatory therapy. Unfortunately, none of these options are consistently effective across the patient population, especially for those with more advanced disease, she said.

Using a case-based approach, Dr. Craiglow will review factors to consider when determining treatment as well the associated risks and benefits of available therapies. For example, while multiple clinical trials have demonstrated hope for JAK inhibitors, these medicines carry risk for potential serious adverse effects.

“A thorough discussion is important so patients can make an informed decision about treatment,” she said.

When formulating treatment plans for pediatric and adult patients with a range of disease severity, Dr. Craiglow said dermatologists should consider several treatment factors.

“There is no one-size-fits-all therapy, and oftentimes combining treatments can yield the best results,” she said. “Although treating patients with AA can be challenging, it is also extremely rewarding. The changing therapeutic landscape means that there is now hope for these patients, and it is so much fun to be able to help them get their hair — and oftentimes their lives — back.”

Dr. Craiglow will be providing her expertise about the best combination treatments within the complex permutations involved, including patient age and disease severity. Factors such as age, extent/location of hair loss, duration of disease, psychosocial impact, and prior therapies will be discussed in depth, as well as emerging therapies.

Visit AAD DermWorld Meeting News Central for more articles.

Interesting Stories
DermWorld | Jan: A Juggling Act
Presented by AAD
DermWorld | Jan: A Juggling Act
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
More in Daily Coverage
Left to right: Taylor Gray, DO, FAAD, and Morgan Brianne Murphrey, MD, MS.
AAD 2023 Annual Meeting
Set yourself up for success
Feb 03, 2023
Img 3020
AAD 2023 Annual Meeting
Management pearls for your practice!
Feb 03, 2023
Getty Images 619236488
AAD 2023 Annual Meeting
These AAD sessions can help you lead the way
Feb 03, 2023
Ben Jacob Friedman, MD, FAAD, and Bridget Shields, MD, FAAD, are leading two, new debate sessions.
AAD 2023 Annual Meeting
We need to talk
Feb 03, 2023
Img 2887
AAD 2023 Annual Meeting
The hottest sessions are back for 2023!
Feb 03, 2023
Img 2929
AAD 2023 Annual Meeting
Exciting industry programs return this year in New Orleans!
Feb 03, 2023
Img 3019
AAD 2023 Annual Meeting
Finish strong. Attend these Tuesday symposiums
Jan 13, 2023
Safi Bahcall, AAD 2023 Annual Meeting Keynote Speaker
AAD 2023 Annual Meeting
Meet keynote speaker Safi Bahcall
Jan 13, 2023
Getty Images 1143723457
AAD 2023 Annual Meeting
Roulez into NOLA for the latest AAD Annual Meeting
Jan 13, 2023
Picture1
AAD 2023 Annual Meeting
Start your session search!
Jan 13, 2023
Venue Photo
AAD 2023 Annual Meeting
Beware of fraudulent meeting registration sites!
Jan 13, 2023
Global Ed Photo
AAD 2023 Annual Meeting
Come a day early for Global Education Day
Jan 13, 2023
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.